Tumor associated macrophages and neutrophils in cancer

被引:511
作者
Galdiero, Maria Rosaria [1 ,2 ]
Bonavita, Eduardo [1 ]
Barajon, Isabella [3 ]
Garlanda, Cecilia [1 ]
Mantovani, Alberto [1 ,3 ]
Jaillon, Sebastien [1 ]
机构
[1] Humanitas Clin & Res Ctr, I-20089 Milan, Italy
[2] Univ Naples Federico II, Div Clin Immunol & Allergy, I-80131 Naples, Italy
[3] Univ Milan, Dept Biotechnol & Translat Med, I-20089 Milan, Italy
基金
欧洲研究理事会;
关键词
Neutrophils; Macrophages; Cancer; Inflammation; ENDOTHELIAL GROWTH-FACTORS; FOSTER IMMUNE PRIVILEGE; NF-KAPPA-B; IN-VIVO; INFILTRATING NEUTROPHILS; METASTATIC PHENOTYPE; INDUCED EXPRESSION; ANGIOGENIC SWITCH; LUNG METASTASIS; CELL MIGRATION;
D O I
10.1016/j.imbio.2013.06.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tumor microenvironment is a complex framework, in which myeloid cells play important roles in sculpting cancer developinent from tumor initiation to metastasis. Immune cells are key participants of the tumor microenvironment where they can promote or inhibit cancer formation and development. Plasticity is a widely accepted hallmark of myeloid cells and in particular of the monocyte-macrophage lineage. It includes the ability to display a wide spectrum of activation states in response to distinct signals and classical M1 or alternative M2 macrophages represent a paradigm of this feature. Neutrophils have long been viewed as terminally differentiated effector cells, playing a major role during the acute phase of inflammation and resistance against microbes. Recent evidence questioned this limited point of view, indicating that neutrophils can interact with distinct cell populations and produce a wide number of cytokines and effector molecules. Therefore, macrophages and neutrophils are both integrated in the regulation of the innate and adaptive immune responses in various inflammatory situations, including cancer. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1402 / 1410
页数:9
相关论文
共 150 条
[1]   Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase [J].
Ai, Shingo ;
Cheng, Xian Wu ;
Inoue, Aiko ;
Nakamura, Kae ;
Okumura, Kenji ;
Iguchi, Akihisa ;
Murohara, Toyoaki ;
Kuzuya, Masafumi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 364 (02) :395-401
[2]   Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment [J].
Allavena, P. ;
Mantovani, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (02) :195-205
[3]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[4]   Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer [J].
Aoyagi, Y ;
Oda, T ;
Kinoshita, T ;
Nakahashi, C ;
Hasebe, T ;
Ohkohchi, N ;
Ochiai, A .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1316-1326
[5]   Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis [J].
Ardi, Veronica C. ;
Kupriyanova, Tatyana A. ;
Deryugina, Elena I. ;
Quigley, James P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (51) :20262-20267
[6]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[7]   CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans [J].
Beatty, Gregory L. ;
Chiorean, Elena G. ;
Fishman, Matthew P. ;
Saboury, Babak ;
Teitelbaum, Ursina R. ;
Sun, Weijing ;
Huhn, Richard D. ;
Song, Wenru ;
Li, Dongguang ;
Sharp, Leslie L. ;
Torigian, Drew A. ;
O'Dwyer, Peter J. ;
Vonderheide, Robert H. .
SCIENCE, 2011, 331 (6024) :1612-1616
[8]   Transforming growth factor beta (TGF-β) and inflammation in cancer [J].
Bierie, Brian ;
Moses, Harold L. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2010, 21 (01) :49-59
[9]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[10]   A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) [J].
Biswas, SK ;
Gangi, L ;
Paul, S ;
Schioppa, T ;
Saccani, A ;
Sironi, M ;
Bottazzi, B ;
Doni, A ;
Vincenzo, B ;
Pasqualini, F ;
Vago, L ;
Nebuloni, M ;
Mantovani, A ;
Sica, A .
BLOOD, 2006, 107 (05) :2112-2122